Search Within

Thoracic Oncology

Formats
  1. Meeting Abstract (1709)
  2. Journal Article (1439)
  3. Review (82)
  4. Editorial (58)
  5. Book Section (35)
  6. Guidelines (25)
  7. Conference Paper (21)
  8. Correspondence (10)
  9. Research Letter (7)
  10. Miscellaneous (6)
  11. Book Whole (2)
Groups
  1. Department of Medicine (3394)
  2. Solid Tumor Oncology Division (3394)
  3. GSK Faculty (1071)
  4. Department of Pathology and Laboratory Medicine (809)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (662)
  6. Human Oncology and Pathogenesis Program (635)

More Groups

People
  1. Mark Kris (872)
  2. Alexander Drilon (637)
  3. Gregory Riely (605)
  4. Charles Rudin (495)
  5. Marc Ladanyi (418)
  6. Matthew Hellmann (412)

More People

Years
  1. 2025 (114)
  2. 2024 (271)
  3. 2023 (273)
  4. 2022 (337)
  5. 2021 (337)
  6. 2020 (258)

More Years

Publications
  1. Journal of Clinical Oncology (703)
  2. Journal of Thoracic Oncology (517)
  3. Annals of Oncology (278)
  4. Clinical Cancer Research (158)
  5. Cancer Research (128)
  6. International Journal of Radiation Oncology, Biology, Physics (89)

More Publications

Publishers
  1. American Society of Clinical Oncology (782)
  2. Elsevier Inc. (738)
  3. American Association for Cancer Research (386)
  4. Oxford University Press (352)
  5. Nature Publishing Group (156)
  6. Elsevier Science, Inc. (79)

More Publishers

Results (3394)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Major pathologic response (<= 10% viable tumor) following neoadjuvant chemotherapy as a surrogate for overall survival in patients with pathologically documented stage IIIA (N2) lung adenocarcinomas
    Meeting Abstract

    Chaft, J. E.; Hellmann, M. D.; Rusch, V. W.; Travis, W. D.; Kris, M. G.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • A phase II study of 18f-FDG PET guided optimization of neoadjuvant chemotherapy for resectable non-small cell lung cancer
    Meeting Abstract

    Chaft, J. E.; Hellmann, M. D.; Dunphy, M.; Jappe, W.; Sima, C. S.; Downey, R. J.; Travis, W. D.; Azzoli, C. G.; Kris, M. G.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Phase 2 study of the GI-4000 KRAS vaccine following curative therapy in patients with stage I-III lung adenocarcinoma harboring a KRAS G12C, G12D, G12V or G12R mutation
    Meeting Abstract

    Chaft, J. E.; Arcila, M.; Patel, P.; Apelian, D. M.; Mattson, A.; Coeshott, C.; Kris, M. G.; Azzoli, C. G.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Targeted cancer genome sequencing in thymic epithelial tumors
    Meeting Abstract

    Moreira, A.; McMillan, R.; Won, H.; Huang, J.; Riely, G.; Ladanyi, M.; Berger, M.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Feedback dependent suppression of mitogenic signaling and its effect on RAF inhibition in BRAFV600E melanomas
    Meeting Abstract

    Lito, P.; Pratilas, C.; Joseph, E.; Tadi, M.; Halilovic, E.; Zubrowski, M.; Huang, A.; de Stanchina, E.; Chandarlapaty, S.; Poulikakos, P.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Feasibility of long-term patient self-reporting of toxicities from home via the internet during routine chemotherapy
    Journal Article

    Judson, T. J.; Bennett, A. V.; Rogak, L. J.; Sit, L.; Barz, A.; Kris, M. G.; Hudis, C. A.; Scher, H. I.; Sabbatini, P.; Schrag, D.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Anaplastic lymphoma kinase (ALK) positive central nervous system (CNS) metastases from non small cell lung cancer (NSCLC)
    Meeting Abstract

    Singer, S.; Riely, G. J.; Kris, M. G.; Grommes, C.
    Neuro-Oncology (2013)

    Fulltext@MSK | Save
  • Systemic bevacizumab (Bev) for leptomeningeal disease (LMD) from non-small cell lung cancer
    Meeting Abstract

    Carlo, M.; Omuro, A.; Grommes, C.; Kris, M.; Nolan, C.; Pentsova, E.; Pietanza, M.; Kaley, T.
    Neuro-Oncology (2013)

    Fulltext@MSK | Save
  • Crizotinib vs. pemetrexed or docetaxel in advanced ALK+ non-small cell lung cancer: Subgroup analysis in PROFILE 1007
    Meeting Abstract

    Yamamoto, N.; Nokihara, H.; Han, J. Y.; Hida, T.; Riely, G. J.; Baldini, E.; Salvatore, S.; Horn, L.; Polli, A.; Satouchi, M.
    Annals of Oncology (2013)

    Fulltext@MSK | Save
  • Crizotinib treatment in patients (pts) with advanced ROS1-rearranged non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Ou, S. H. I.; Kim, D. W.; Camidge, R.; Riely, G. J.; Salgia, R.; Shapiro, G.; Clark, J. W.; Tye, L.; Iafrate, A. J.; Shaw, A.
    Annals of Oncology (2013)

    Fulltext@MSK | Save